{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:18:22Z","timestamp":1787649502367,"version":"build-2736575974"},"reference-count":20,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy Carol Davila"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Objectives. To examine, in an exploratory institutional cohort, whether a registry record of cerebrospinal fluid (CSF) diversion was associated with the available binary registry outcome status in children with medulloblastoma, while distinguishing this intervention-related variable from radiographic hydrocephalus. Methods. We performed a retrospective single-institution cohort study of 85 patients younger than 18 years with histologically confirmed medulloblastoma who underwent surgical treatment at the Neurosurgery Unit of Bagdasar-Arseni Emergency Hospital. The exposure was any source-record indication of external ventricular drainage, shunting, or ventriculocisternostomy. The analytic file did not provide the timing, indication, or standardized type of diversion; therefore, the exposure could not be characterized as occurring at presentation or before tumor resection. The outcome was the database field labelled \u201cfive-year survival,\u201d coded as alive or death\/event. Dates of diagnosis, death, progression, and last follow-up were unavailable, so uniform five-year ascertainment and the meaning of \u201cevent\u201d could not be verified. Descriptive analyses, univariable comparisons, and a parsimonious logistic model including recorded CSF diversion and metastatic disease were performed. Results. The median age was 6 years (IQR, 3\u201311), and 47 patients were male (55.3%). Hydrocephalus was recorded in 67 patients (78.8%), any CSF diversion in 40 (47.1%), metastatic disease in 12 (14.1%), and gross-total resection in 64 (75.3%). The registry outcome was recorded as alive in 56 patients (65.9%) and death\/event in 29 (34.1%). The recorded death\/event category occurred in 24\/40 patients with diversion versus 5\/45 without diversion (60.0% vs. 11.1%; p &lt; 0.001), and in 9\/12 patients with metastasis versus 20\/73 without metastasis (75.0% vs. 27.4%; p = 0.002). In the mutually adjusted exploratory model, recorded CSF diversion was associated with the death\/event category (OR, 12.71; 95% CI, 3.75\u201343.05; p &lt; 0.001), as was metastatic disease (OR, 8.93; 95% CI, 1.66\u201347.91; p = 0.011). Conclusions. Recorded CSF diversion was associated with adverse registry outcome status after mutual adjustment for metastatic disease. Given uncertainty regarding timing and indication, possible outcome misclassification, the small number of recorded events, and absent clinical, treatment, and molecular covariates, this finding should be interpreted as an exploratory institutional association that may reflect disease severity and management selection, not procedural causality or validated prognostic value.<\/jats:p>","DOI":"10.3390\/jcm15176544","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:00:48Z","timestamp":1787644848000},"page":"6544","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Recorded Cerebrospinal Fluid Diversion with Registry Outcome Status in Pediatric Medulloblastoma: An Exploratory 10-Year Single-Centre Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-0893","authenticated-orcid":false,"given":"Radu-Eugen","family":"Rizea","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Neurosurgery, Bagdasar-Arseni Clinical Emergency Hospital, 041915 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Lidia","family":"Gheorghita","sequence":"additional","affiliation":[{"name":"Private Practice Pediatric Neurology, 031871 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40478-024-01848-2","article-title":"Systematic Transcriptomic Analysis of Childhood Medulloblastoma Identifies N6-Methyladenosine-Dependent lncRNA Signatures Associated with Molecular Subtype, Immune Cell Infiltration, and Prognosis","volume":"12","author":"Joshi","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-023-02566-0","article-title":"Molecular Characterisation Defines Clinically-Actionable Heterogeneity within Group 4 Medulloblastoma and Improves Disease Risk-Stratification","volume":"145","author":"Goddard","year":"2023","journal-title":"Acta Neuropathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/neuonc\/noae178","article-title":"Molecular and Clinical Heterogeneity within MYC-Family Amplified Medulloblastoma Is Associated with Survival Outcomes: A Multicenter Cohort Study","volume":"27","author":"Schwalbe","year":"2025","journal-title":"Neuro-Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/neuonc\/noae111","article-title":"Medulloblastoma in Children with Fanconi Anemia: Association with FA-D1\/FA-N, SHH Type and Poor Survival Independent of Treatment Strategies","volume":"26","author":"Sauerbrey","year":"2024","journal-title":"Neuro-Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/14737140.2024.2357807","article-title":"Risk-Stratification for Treatment de-Intensification in WNT-Pathway Medulloblastoma: Finding the Optimal Balance between Survival and Quality of Survivorship","volume":"24","author":"Gupta","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, Y., Mizumoto, M., Oshiro, Y., Maruo, K., Inaba, M., Saito, T., Hosaka, S., Iizumi, T., Fukushima, H., and Suzuki, R. (2025). Systematic Review and Meta-Analysis of Proton Beam Therapy Versus Photon Radiotherapy for Medulloblastoma: TRP-Medulloblastoma 2025. Cancers, 17.","DOI":"10.3390\/cancers17132191"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"vdaf086","DOI":"10.1093\/noajnl\/vdaf086","article-title":"Outcomes of Pediatric Medulloblastoma in Low- and Middle-Income Countries: A Retrospective Analysis of 335 Cases from 8 Countries","volume":"7","author":"Alcasabas","year":"2025","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000523709","article-title":"Cerebrospinal Fluid Homeostasis and Hydrodynamics: A Review of Facts and Theories","volume":"85","author":"Theologou","year":"2022","journal-title":"Eur. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100205","DOI":"10.1016\/j.ejcped.2024.100205","article-title":"Medulloblastoma Therapy: Consensus Treatment Recommendations from SIOP-Europe and the European Reference Network","volume":"5","author":"Bailey","year":"2025","journal-title":"EJC Paediatr. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral Heterogeneity within Medulloblastoma Subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/2019.5.PEDS18381","article-title":"Medulloblastoma in the Age of Molecular Subgroups: A Review","volume":"24","author":"Juraschka","year":"2019","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ismail, M., Um, H., Salloum, R., Hollnagel, F., Ahmed, R., De Blank, P., and Tiwari, P. (2024). A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study. Cancers, 16.","DOI":"10.3390\/cancers16122248"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.18632\/oncotarget.23773","article-title":"Comparing Children and Adults with Medulloblastoma: A SEER Based Analysis","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"ref_14","first-page":"240","article-title":"Management of Hydrocephalus in Children with Medulloblastoma: Prognostic Factors for Shunting","volume":"20","author":"Lee","year":"1994","journal-title":"Pediatr. Neurosurg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e14062","DOI":"10.1200\/JCO.2023.41.16_suppl.e14062","article-title":"Ventriculoperitoneal Shunt and Performance Status as Prognostic Factors of Overall Survival in a Retrospective Cohort of 78 Adult Patients with Medulloblastoma","volume":"41","author":"Merida","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3171\/2014.9.PEDS14280","article-title":"Clinical Implications of Medulloblastoma Subgroups: Incidence of CSF Diversion Surgery","volume":"15","author":"Schneider","year":"2015","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10143-023-02080-7","article-title":"The Insertion and Management of an External Ventricular Drain in Pediatric Patients with Hydrocephalus Associated with Medulloblastoma","volume":"46","author":"Zhang","year":"2023","journal-title":"Neurosurg. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pediatrneurol.2023.06.016","article-title":"Incidence and Risk Factors for Necessitating Cerebrospinal Fluid Diversion Following Medulloblastoma Surgery in Children","volume":"146","author":"Zhang","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3171\/2024.12.PEDS24424","article-title":"Optimal Management of Hydrocephalus in Children with Posterior Fossa Tumors: An International Retrospective Multicenter Study","volume":"35","author":"Henriksen","year":"2025","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1038\/s41598-020-66328-8","article-title":"Long-Term Outcome of Posterior Fossa Medulloblastoma in Patients Surviving More than 20 Years Following Primary Treatment in Childhood","volume":"10","author":"Fric","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6544\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:18:38Z","timestamp":1787645918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":20,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176544"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176544","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}